A detailed history of Milestone Asset Management, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Milestone Asset Management, LLC holds 155,127 shares of CRBU stock, worth $426,599. This represents 0.07% of its overall portfolio holdings.

Number of Shares
155,127
Previous 142,310 9.01%
Holding current value
$426,599
Previous $233 Million 30.28%
% of portfolio
0.07%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$1.56 - $2.73 $19,994 - $34,990
12,817 Added 9.01%
155,127 $304 Million
Q2 2024

Jul 19, 2024

BUY
$1.62 - $5.05 $230,542 - $718,665
142,310 New
142,310 $233 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $167M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Milestone Asset Management, LLC Portfolio

Follow Milestone Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Milestone Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Milestone Asset Management, LLC with notifications on news.